Our results raise the possibility that BCR/TLR signaling, perhaps in response to tumor antigens and nucleic acids released by dying tumor cells in the necrotic core, may support B-cell checkpoint signaling in the TME to drive PD-L1 expression. This evidence concerns the gene BCR and neoplasm.